Deccan Health Care Limited (BOM:542248)
India
· Delayed Price · Currency is INR 12.74
+0.32 (2.58%)
At close: Mar 10, 2026
Deccan Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 816.77 | 750.58 | 597.29 | 450.22 | 331.71 | 337.76 | Upgrade
|
| Revenue Growth (YoY) | 16.22% | 25.66% | 32.67% | 35.73% | -1.79% | -20.05% | Upgrade
|
| Cost of Revenue | 520.7 | 475.86 | 375.72 | 250.18 | 144.83 | 186.91 | Upgrade
|
| Gross Profit | 296.07 | 274.72 | 221.57 | 200.04 | 186.88 | 150.85 | Upgrade
|
| Selling, General & Admin | 53.65 | 45.42 | 36.24 | 33.79 | 21.95 | 29.18 | Upgrade
|
| Other Operating Expenses | 194.41 | 197.79 | 147.82 | 146.63 | 107.29 | 101.06 | Upgrade
|
| Operating Expenses | 262.48 | 257.74 | 198.73 | 194.69 | 143.97 | 144.89 | Upgrade
|
| Operating Income | 33.59 | 16.99 | 22.84 | 5.35 | 42.91 | 5.96 | Upgrade
|
| Interest Expense | -2.21 | -0.58 | -0.56 | -0.86 | -1.13 | -0.76 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.14 | 0.16 | 0.04 | 0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.05 | -0.12 | -0.28 | -0.26 | 0.44 | -0.08 | Upgrade
|
| EBT Excluding Unusual Items | 31.34 | 16.3 | 22.14 | 4.4 | 42.26 | 5.19 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -2.84 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -34 | - | Upgrade
|
| Pretax Income | 31.34 | 16.3 | 22.14 | 4.4 | 5.43 | 5.19 | Upgrade
|
| Income Tax Expense | 8.57 | 4.72 | 7.21 | 1.34 | 2.2 | 1.29 | Upgrade
|
| Net Income | 22.77 | 11.59 | 14.93 | 3.06 | 3.23 | 3.9 | Upgrade
|
| Net Income to Common | 22.77 | 11.59 | 14.93 | 3.06 | 3.23 | 3.9 | Upgrade
|
| Net Income Growth | 95.73% | -22.37% | 387.62% | -5.12% | -17.26% | -96.14% | Upgrade
|
| Shares Outstanding (Basic) | 24 | 22 | 19 | 13 | 16 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 25 | 26 | 19 | 13 | 16 | 16 | Upgrade
|
| Shares Change (YoY) | 1.42% | 38.37% | 45.91% | -18.83% | - | - | Upgrade
|
| EPS (Basic) | 0.94 | 0.54 | 0.80 | 0.24 | 0.21 | 0.25 | Upgrade
|
| EPS (Diluted) | 0.91 | 0.45 | 0.80 | 0.24 | 0.21 | 0.25 | Upgrade
|
| EPS Growth | 93.62% | -43.75% | 233.33% | 16.90% | -17.26% | -96.14% | Upgrade
|
| Free Cash Flow | - | -67.47 | -127.92 | -67.65 | -6.85 | 0.61 | Upgrade
|
| Free Cash Flow Per Share | - | -2.62 | -6.87 | -5.30 | -0.44 | 0.04 | Upgrade
|
| Gross Margin | 36.25% | 36.60% | 37.10% | 44.43% | 56.34% | 44.66% | Upgrade
|
| Operating Margin | 4.11% | 2.26% | 3.82% | 1.19% | 12.93% | 1.76% | Upgrade
|
| Profit Margin | 2.79% | 1.54% | 2.50% | 0.68% | 0.97% | 1.15% | Upgrade
|
| Free Cash Flow Margin | - | -8.99% | -21.42% | -15.02% | -2.07% | 0.18% | Upgrade
|
| EBITDA | 48.01 | 31.51 | 37.51 | 19.62 | 57.63 | 20.62 | Upgrade
|
| EBITDA Margin | 5.88% | 4.20% | 6.28% | 4.36% | 17.37% | 6.11% | Upgrade
|
| D&A For EBITDA | 14.42 | 14.53 | 14.67 | 14.28 | 14.73 | 14.66 | Upgrade
|
| EBIT | 33.59 | 16.99 | 22.84 | 5.35 | 42.91 | 5.96 | Upgrade
|
| EBIT Margin | 4.11% | 2.26% | 3.82% | 1.19% | 12.93% | 1.76% | Upgrade
|
| Effective Tax Rate | 27.33% | 28.92% | 32.58% | 30.38% | 40.53% | 24.89% | Upgrade
|
| Revenue as Reported | 816.89 | 750.64 | 597.44 | 450.41 | 333.92 | 338.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.